Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on
top health stories.
Ebola could kill 90,000 in Liberia by year-end unless efforts scaled up: study
24 Oct 2014 at 5:27am
By Magdalena Mis LONDON (Thomson Reuters Foundation) - Efforts to control the Ebola virus in Liberia must be quickly and dramatically scaled up or tens of thousands of people will die in the coming months, said a study published on Friday. Nearly 4,900 deaths have been recorded across West Africa since the virus was first detected in Guinea in March, according to the World Health Organization. Liberia has been the hardest hit of the countries most affected by the virus, with 2,705 deaths and 4,665 recorded cases. ...
WHO expects around 200,000 Ebola vaccine doses by mid: 2015
24 Oct 2014 at 5:26am
GENEVA/LONDON (Reuters) - The World Health Organization (WHO) set out plans on Friday for speeding up development and deployment of experimental Ebola vaccines, saying hundreds of thousands of doses should be ready for use in West Africa by the middle of 2015. The Geneva-based United Nations health agency confirmed that two leading vaccine candidates are already in human clinical trials, and said another five experimental vaccines were also being developed and would begin clinical trials next year. "Before the end of first half of 2015..we could have available a few hundred thousand doses. ...
Futures decline on weak Amazon results, Ebola concern
24 Oct 2014 at 5:24am
By Chuck Mikolajczak NEW YORK (Reuters) - U.S. stock index futures fell on Friday, putting the S&P 500 on track to trim its weekly advance, following disappointing earnings from Amazon and as the first diagnosed case of Ebola in New York City raised concerns about the spread of the virus. Amazon plunged 9.9 percent to $282.23 in premarket trade after the online retailer's sales projections for the crucial holiday quarter disappointed Wall Street and third-quarter results missed forecasts. Microsoft , up 2.6 percent at $46. ...
Doctor with Ebola in New York hospital after return from Guinea
24 Oct 2014 at 5:22am
By Ellen Wulfhorst and Sebastien Malo NEW YORK (Reuters) - A doctor who worked in West Africa with Ebola patients was in an isolation unit in New York City on Friday after testing positive for the virus, becoming the fourth person diagnosed with the disease in the United States and the first in its largest city. Dr. Craig Spencer, 33, was placed in a quarantined unit at Bellevue Hospital on Thursday, six days after returning from Guinea, renewing public jitters about transmission of the disease and rattling financial markets. ...
Canadian consulate in Istanbul gets package containing yellow powder: Turkish...
24 Oct 2014 at 5:08am
ISTANBUL (Reuters) - Turkish authorities on Friday launched an investigation after an unidentified yellow powder was found in a package sent to the Canadian consulate in Istanbul. "The letter containing a yellow substance was examined in line with regular procedures," Turkey's disaster management agency, AFAD, said in a statement. One Canadian consulate employee came directly into contact with the suspicious package and six others had indirect exposure, the statement said. The German and Belgian consulates also received similar packages containing the yellow powder, Turkish media reported. ...
EU backs drug for rare sun intolerance from Australia's Clinuvel
24 Oct 2014 at 5:06am
LONDON (Reuters) - European patients with a rare genetic disease that causes intolerance to sunlight should soon have a new treatment option, following a green light for a drug from Australia's Clinuvel Pharmaceuticals. The biotech company is pinning its hopes on Scenesse, the first medicine for preventing phototoxicity in adults with erythropoietic protoporphyria (EPP). After exposure to sunlight, patients with EPP feel a stinging pain in sun-exposed skin and prolonged exposure can lead to an incapacitating pain, often followed by redness and swelling. ...
Beds at Ebola treatment units empty in Liberia
24 Oct 2014 at 5:03am
MONROVIA, Liberia (AP) ? Even as Liberians fall ill and die of Ebola, many beds in treatment centers are empty because of the government's order that the bodies of all suspected Ebola victims in the capital be cremated, authorities have determined.
Europe backs continued use of Ariad Pharma's leukemia drug
24 Oct 2014 at 5:03am
(Reuters) - European regulators recommended continued use of Ariad Pharmaceuticals Inc's cancer drug Iclusig in its already approved indications to treat certain kinds of leukemia. However, the European Medicines Agency (EMA) recommended additional warnings in Iclusig's European product information to minimize the risk of vascular events, Ariad said on Friday. The decision follows a positive recommendation from the EMA's Pharmacovigilance Risk Assessment Committee, which said earlier this month that the benefits of Iclusig continued to outweigh its risks. ...
After 1st Ebola case in NYC, 3 others quarantined
24 Oct 2014 at 5:02am
NEW YORK (AP) ? A doctor who became New York City's first Ebola patient was praised for getting treatment immediately upon showing symptoms, and health officials stressed that the nation's most populous city need not fear his wide-ranging travel in the days before his illness began.
AstraZeneca cancer drug pipeline gets boost from European green light
24 Oct 2014 at 4:47am
By Ben Hirschler LONDON (Reuters) - AstraZeneca's cancer drug pipeline received a boost on Friday, as European regulators recommended approval of an experimental medicine against ovarian cancer. The green light from the European Medicines Agency (EMA) for olaparib, or Lynparza, is welcome news since the product hit a road bump in June when a U.S. panel voted against its accelerated approval. AstraZeneca has flagged the medicine as a potential $2 billion-a-year seller. Olaparib blocks an enzyme involved in cell repair and is designed for patients with certain hereditary gene mutations. ...
Pakistan detects more polio cases on awareness day
24 Oct 2014 at 4:36am
ISLAMABAD (AP) ? World Health Organization says three more polio cases have surfaced in Pakistan, bringing the number of those affected by the crippling disease in the country this year to 220.
New York confirms first Ebola case
24 Oct 2014 at 4:28am
New York confirmed the first case of Ebola in the largest city in the United States as the EU dramatically ramped up aid Friday to contain the killer epidemic ravaging west Africa. The EU announcement of one billion euros ($1.3 billion) for the worst-hit countries comes as fears of a spread of the virus grew, with the first confirmed case in Mali, where a two-year-old girl has tested positive. The World Health Organization (WHO), which has warned the Ebola crisis in west Africa "remains of great concern", held talks Thursday on efforts to ensure access to and funding for potential vaccines. The New York case is a doctor who recently returned from treating Ebola patients in Guinea, the epicenter of the world's worst outbreak of the disease.
Cameron: EU secures $1.25 billion for Ebola fight
24 Oct 2014 at 3:56am
BRUSSELS (AP) ? British Prime Minister David Cameron says that the European Union and its 28 member nations have secured 1 billion euros ($1.25 billion) to fight the Ebola crisis in West Africa.
WHO sending Ebola experts to Mali, 43 people monitored for virus
24 Oct 2014 at 3:47am
GENEVA (Reuters) - The World Health Organization (WHO) said on Friday it was sending more experts to help Mali fight Ebola, a day after the first case of the disease was confirmed there. Malian authorities said on Thursday a two-year-old girl who had traveled to neighboring Guinea was infected -- making Mali the sixth West African country to be touched by the worst outbreak on record of the hemorrhagic fever, which has killed almost 4,900 people. . ...
Hikma Pharma shares slip on FDA warning for Portugal plant
24 Oct 2014 at 3:45am
(Reuters) - Drugmaker Hikma Pharmaceuticals Plc said the U.S. health regulator had raised issues related to environmental monitoring at its plant in Portugal, which some analysts said accounts for about a quarter of the company's U.S. injectibles sales. Shares in the Jordanian company fell more than 6 percent on Friday as the warning added to disappointment of weak branded drug sales and a case filed by Takeda Pharmaceutical Co against the approval of Hikma's drug for gout flares. Hikma's stock was the top percentage loser on the FTSE-250 Midcap Index in the morning. ...